PETROS PHARMACEUTICALS INC (PTPI)       2.66  +0.03 (+1.14%)

2.66  +0.03 (+1.14%)

US71678J2096 - Common Stock - After market: 2.56 -0.1 (-3.76%)

PETROS PHARMACEUTICALS INC2.66

NASDAQ:PTPI (1/30/2023, 7:16:59 PM)+0.03 (+1.14%)

After market: 2.56 -0.1 (-3.76%)

Chartmill TA Rating
Chartmill Setup Rating
Sector
GICS Sector Health Care
GICS Industry Pharmaceuticals

Chartmill FA Rating
Valuation Growth
Profitability Health
Dividend

Overview
Earnings (Last) 11-15 2022-11-15/bmo Earnings (Next) N/A N/A
Ins Owners 0.55% Inst Owners 33.46%
Market Cap 5.51M Shares 2.07M
PE N/A Fwd PE N/A
Dividend Yield N/A Analysts N/A
IPO 12-02 2020-12-02

Stock Screener Links

Screen Image

Nasdaq Stock Screener

Find more stocks on Nasdaq

Screen Image

USA Stock Screener

Find more stocks on the USA

Screen Image

GICS Sector Stock Screener

Find competitors from the same sector on the USA

Screen Image

GICS Industry Stock Screener

Find competitors from the same industry on the USA

Screen Image

Technical Stock Screener

Find stocks with similar TA and Setup ratings on the USA

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Technical Competitors Stock Screener

Find the competitors with the best technical ratings on the USA

Screen Image

Best Technical Setups Competitors Stock Screener

Find the competitors with the best technical and setup ratings on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA

Screen Image

Best Analyst Rating Competitors Stock Screener

Find the competitors with the best analyst ratings on the USA

PTPI Daily chart

Company Profile

Petros Pharmaceuticals Inc is a US-based company operating in Pharmaceuticals industry. The company is headquartered in New York City, New York and currently employs 24 full-time employees. The company went IPO on 2020-12-02. Petros Pharmaceuticals, Inc. is a pharmaceutical company focused on men's health therapeutics with a range of commercial capabilities including sales, marketing, regulatory and medical affairs, finance, trade relations, pharmacovigilance, market access relations, manufacturing, and distribution. The firm is also focused on identifying, developing, acquiring, and commercializing therapeutics for men's health issues, including, erectile dysfunction (ED), endothelial dysfunction, psychosexual and psychosocial ailments, peyronie's disease, hormone health, and substance use disorders. The firm also markets its own line of ED products in the form of vacuum erection device (VED) products through its subsidiaries, Timm Medical, Inc. In addition, its ED products, the Company is focused on identifying and developing other pharmaceuticals to advance men's health, which is H100, which is the topical formulation candidate for the treatment of acute peyronie's disease.

Company Info

PETROS PHARMACEUTICALS INC

1185 Avenue Of The Americas, 3Rd Floor, Suite 570

New York City NEW YORK 10036

P: 19732420005.0

CEO: John D. Shulman

Employees: 24

PTPI News

News Image3 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Pre-market stock movers continue to be a major topic as we dive into the latest news investors need to know about on Friday!

News Image6 months ago - Petros Pharmaceuticals, Inc.Petros Pharmaceuticals Reports Record Revenue and Gross Profit During Second Quarter 2022

NEW YORK, NY / ACCESSWIRE / August 15, 2022 / Petros Pharmaceuticals, Inc. ("Petros" or "the Company") (NASDAQ:PTPI), a leading provider of therapeutics for men's health, today announced financial results for the second quarter ended June 30, 2022.

News Image6 months ago - InvestorPlaceWhat Is Going on With Petros Pharmaceuticals (PTPI) Stock Today?

In perhaps one of the most incredible turn of events we've seen in some time, PTPI stock has nearly round-tripped from a 260% move today.

News Image6 months ago - Petros Pharmaceuticals, Inc.Petros Pharmaceuticals Responds to Fraudulent Press Release

NEW YORK, July 28, 2022 (GLOBE NEWSWIRE) -- Petros Pharmaceuticals, Inc. (Nasdaq: PTPI), a leading provider of therapeutics for men’s health, today...

News Image7 months ago - Petros Pharmaceuticals, Inc.Petros Pharmaceuticals Kicks Off Social Media Campaign with Celebrity Physician Dr. Drew Pinsky

Dr. Drew to Raise Awareness of Petros Pharmaceuticals’ Mission in The Men’s Health Category and STENDRA® (avanafil)...

News Image8 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Welcome back and get ready because we're starting off the week with a breakdown of the biggest pre-market stock movers for Tuesday!

PTPI Twits

Here you can normally see the latest stock twits on PTPI, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.

Example Twits:

Twits example